Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis

Marie Louise Zeissler; Jordan Eastwood; Kieran McCorry; Oliver O. Hanemann; John P. Zajicek; Camille B. Carroll

doi:10.18632/oncotarget.10314

Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis

Marie Louise Zeissler, Jordan Eastwood, Kieran McCorry, Oliver O. Hanemann, John P. Zajicek, Camille B. Carroll^*

^*Corresponding author for this work

Peninsula Medical School

University of St Andrews

Research output: Contribution to journal › Article › peer-review

8 Downloads (Pure)

Original language	English
Number of pages	0
Journal	Oncotarget
Volume	0
Issue number	0
DOIs	https://doi.org/10.18632/oncotarget.10314
Publication status	Published - 27 Jun 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.18632/oncotarget.10314

10314-156977-2-PB paper pdf

Cite this

@article{f940ef41ebc74831be5e9eaac1551bed,

title = "Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis",

author = "Zeissler, {Marie Louise} and Jordan Eastwood and Kieran McCorry and Hanemann, {Oliver O.} and Zajicek, {John P.} and Carroll, {Camille B.}",

year = "2016",

month = jun,

day = "27",

doi = "10.18632/oncotarget.10314",

language = "English",

volume = "0",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "0",

}

TY - JOUR

T1 - Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis

AU - Zeissler, Marie Louise

AU - Eastwood, Jordan

AU - McCorry, Kieran

AU - Hanemann, Oliver O.

AU - Zajicek, John P.

AU - Carroll, Camille B.

PY - 2016/6/27

Y1 - 2016/6/27

U2 - 10.18632/oncotarget.10314

DO - 10.18632/oncotarget.10314

M3 - Article

SN - 1949-2553

VL - 0

JO - Oncotarget

JF - Oncotarget

IS - 0

ER -